Team Youn Bio Medicine International Corp. Limited
Team Youn Bio Medicine International Corp. Limited, commonly referred to as Team Youn Bio Medicine, is a prominent player in the biotechnology industry, headquartered in Hong Kong. Founded in [year not specified], the company has established itself as a leader in the development of innovative biopharmaceuticals and advanced therapeutic solutions, primarily focusing on oncology and autoimmune diseases. With a strong operational presence across Asia and beyond, Team Youn Bio Medicine is recognised for its unique approach to drug development, leveraging cutting-edge research and technology. The company’s core products include targeted therapies that stand out for their efficacy and safety profiles, addressing unmet medical needs in challenging therapeutic areas. Notable achievements include significant partnerships and collaborations that have enhanced its market position, solidifying Team Youn Bio Medicine's reputation as a forward-thinking entity in the global biomedicine landscape.
DitchCarbon Score
How does Team Youn Bio Medicine International Corp. Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Team Youn Bio Medicine International Corp. Limited's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Team Youn Bio Medicine International Corp. Limited's reported carbon emissions
In 2019, Team Youn Bio Medicine International Corp. Limited, headquartered in Hong Kong (HK), reported significant carbon emissions totalling approximately 15,132,780 kg CO2e for Scope 1 and about 32,896,560 kg CO2e for Scope 2. This data reflects their direct and indirect emissions from energy consumption and operational activities. Comparatively, in 2018, the company recorded Scope 1 emissions of around 13,450,950 kg CO2e and Scope 2 emissions of about 29,340,110 kg CO2e. This indicates an increase in both scopes over the year, highlighting the need for enhanced climate action. Currently, Team Youn Bio Medicine International Corp. Limited has not established specific reduction targets or initiatives, nor do they participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The absence of Scope 3 emissions data suggests a potential area for future reporting and improvement. As the company continues to navigate its environmental impact, the focus on transparency and commitment to reducing emissions will be crucial in aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | |
|---|---|---|
| Scope 1 | 13,450,950 | 00,000,000 |
| Scope 2 | 29,340,110 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Team Youn Bio Medicine International Corp. Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
